Stockreport

Obalon down 32% on soft Q1 sales [Seeking Alpha]

OBALON THERAPEUTICS  (OBLN) 
Last obalon therapeutics earnings: 11/8 07:15 am Check Earnings Report
US:NASDAQ Investor Relations: investor.obalon.com
PDF Obalon down 32% on soft Q1 salesThinly traded nano cap Obalon Therapeutics (OBLN-31.5%) slumps on more than a 4x surge in volume, albeit on turnover of only 277K shares, [Read more]